NL-OMON49566CompletedNot Applicable
One year follow-up in FSHD: biomarkers and outcome measures on the road to therapy - FSHD-FOCUS 2.1
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 100
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •100 genetically confirmed FSHD patients that participated in the FSHD-FOCUS 2
- •study (CMO 2014-121) who underwent muscle ultrasound as part of the study.
Exclusion Criteria
- •1. Incapacitated persons will not be included in this study.
- •2. Patients who are unable to visit the Radboudumc.
Investigators
Similar Trials
Recruiting
Not Applicable
One year follow-up in FSHD: biomarkers and outcome measures on the road to therapyFSHDNL-OMON28492Radboudumc100
Completed
Not Applicable
FSHD Longitudinal Biomarker Preparatory Studyspierziekte10028396FSHDNL-OMON46095Fulcrum Therapeutics6
Recruiting
Not Applicable
Ten year follow-up in FSHD: the FOCUS-3 studyFSHD (facioscapulohumeral muscular dystrophy)Landouzy Dejerine disease1002839610029317NL-OMON56838Radboud Universitair Medisch Centrum200
Recruiting
Not Applicable
HD-med: A longitudinal, observational study to assess medication use, medication efficacy and the role of pharmacogenetics in Huntington*s Disease.Huntington's DiseaseHuntington's chorea (outdated terminology)1008362410028037NL-OMON55123eids Universitair Medisch Centrum391
Recruiting
Unknown
HD-MED: Aiming to personalize drug treatment in Huntington’s DiseaseNL-OMON23607eiden University Medical Center (investigator-initiated)391